Latest 2 stories · newest Oct 9, 2026
The Series A Convertible Preferred Stock was previously converted entirely into Common Stock, and the Serina Board has now authorized the elimination of this class of stock entirely.
Serina Therapeutics filed an amendment to its certificate of incorporation increasing authorized common shares to 125 million and preferred shares to 5 million. This increase provides flexibility for future equity funding or stock-based compensation.
The same SRNA feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/SRNA/newsSTART FREE